Zaballa, M. E., Perez-Saez, J., de Mestral, C., Pullen, N., Lamour, J., Turelli, P., Raclot, C., Baysson, H., Pennacchio, F., Villers, J., Duc, J., Richard, V., Dumont, R., Semaani, C., Loizeau, A. J., Graindorge, C., Lorthe, E., Balavoine, J. F., Pittet, D., Schibler, M., Vuilleumier, N., Chappuis, F., Kherad, O., Azman, A. S., Posfay-Barbe, K. M., Kaiser, L., Trono, D., Stringhini, S., Guessous, I., Specchio, Covid study group

(2023). Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in Geneva, Switzerland: a population-based study : The Lancet regional health - Europe.

https://doi.org/10.1016/j.lanepe.2022.100547

Auteur(s) : Elsa Lorthe